Cargando…
Revisiting Estrogen: Efficacy and Safety for Postmenopausal Bone Health
The rapid decline in endogenous estrogen production that occurs during menopause is associated with significant bone loss and increased risk for fragility fracture. While hormone therapy (HT) is an effective means to re-establish endogenous estrogen levels and reduce the risk of future fracture, its...
Autores principales: | Sacco, Sandra M., Ward, Wendy E. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2957171/ https://www.ncbi.nlm.nih.gov/pubmed/20981150 http://dx.doi.org/10.4061/2010/708931 |
Ejemplares similares
-
Efficacy and safety of bazedoxifene for postmenopausal osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2011) -
The Ovariectomized Rat as a Model for Studying Alveolar Bone Loss in Postmenopausal Women
por: Johnston, Bryan D., et al.
Publicado: (2015) -
Estrogens and Neuropeptides in Postmenopausal Women: Un Update
por: Guida, M., et al.
Publicado: (2012) -
Postmenopausal endometriosis: An enigma revisited
por: Shah, Duru
Publicado: (2014) -
The Efficacy of Selective Estrogen Receptor Modulators Monotherapies in Postmenopausal Women with Osteopenia
por: Kim, Kyung Wook, et al.
Publicado: (2022)